Genetic profiling can guide stem cell transplantation for patients with myelodysplastic syndrome
(Dana-Farber Cancer Institute) A single blood test and basic information about a patient's medical status can indicate which patients with myelodysplastic syndrome (MDS) are likely to benefit from a stem cell transplant, according to new research by scientists at Dana-Farber Cancer Institute.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | Myelodysplastic Syndrome | Stem Cell Therapy | Stem Cells | Transplants